$ACOG

$8.88 +$0.58 (6.99%) Live

$ACOG Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$ACOG Management Team

Mr. Len Mertz

Independent Chairman of the Board

Age 69

Compensation -

Sex Male

Mr. Michael Mcfadden

Chief Executive Officer

Director

Age 57

Compensation $786.2K USD

Sex Male

Mr. Henry Du

Interim Chief Financial Officer

Vice President - Finance and Accounting

Age 46

Compensation -

Sex Male

Ms. Lauren D'Angelo

Chief Operating Officer

Age 46

Compensation $660.3K USD

Sex Female

Mr. Kenneth Cawkell

Corporate Secretary

Director

Age 74

Compensation $97.23K USD

Sex Male

Mr. Robert Lynch

Investor Relations

Age -

Compensation -

Sex Male

Name / Title	Age	Compensation	Sex
Mr. Len Mertz Independent Chairman of the Board	69	-	Male
Mr. Michael Mcfadden Chief Executive Officer Director	57	$786.2K USD	Male
Mr. Henry Du Interim Chief Financial Officer Vice President - Finance and Accounting	46	-	Male
Ms. Lauren D'Angelo Chief Operating Officer	46	$660.3K USD	Female
Mr. Kenneth Cawkell Corporate Secretary Director	74	$97.23K USD	Male
Mr. Robert Lynch Investor Relations	-	-	Male

Board of Directors

From the proxy statement filed Apr 30, 2026

Directors

serving now

Independent

5 of 5

stated in the proxy; 2 not stated

Average tenure

4.3 years

from year joined

CEO also chairs the board

Len Mertz

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Michael McFadden CEO	58	2021 5 years	Not stated	None stated	None stated	Paid as CEO
Kenneth Cawkell	74	2021 5 years	Not stated	None stated	Westmount Minerals Corp., Portofino Resources Inc., Centurion Minerals Inc., Well Health Technologies Corp.	$246,000
Rajeev “Rob” Bakshi	66	2017 9 years	Independent	None stated	None stated	$248,500
Phillip Mertz	41	2021 5 years	Independent	None stated	None stated	Not stated
Robert Wills	72	2025 1 year	Independent	None stated	Milestone Pharmaceuticals, Inc., Oncternal Therapeutics	$185,000
Bethany Sensenig	50	2026 0 years	Independent	None stated	Supernus Pharmaceuticals, KalVista Pharmaceuticals	Not stated
Len Mertz Leaving at the meeting Board chair	70	2021 5 years	Independent	Audit Committee · Chair	None stated	Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

1 disclosed in the proxy filed Apr 30, 2026

Neurodyn Life Sciences Inc.

a former related party through common shareholders and management

US$1,400,000

March 2015

Promissory note issued by the Company to Neurodyn, later amended to change interest rate and maturity date.

With the Company Open in proxy

Comments

Company Executives

$ACOG Management Team

Mr. Len Mertz

Mr. Michael Mcfadden

Mr. Henry Du

Ms. Lauren D'Angelo

Mr. Kenneth Cawkell

Mr. Robert Lynch

Board of Directors

Related-party transactions